The safety profile of drug treatment of alzheimer's disease
Despite the fact that Alzheimer's disease is being intensively studied for many years, its main etiopathogenic mechanisms are still unknown. At the same time, given the prognosis of the disease and its prevalence, the problem of adequate medical treatment is an important medical and social prob...
Main Author: | V. А. Moroz |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2013-06-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/13572/11931 |
Similar Items
-
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
by: Clive Ballard, et al.
Published: (2013-10-01) -
Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
by: Marcin Sochal, et al.
Published: (2019-12-01) -
Drug candidates in clinical trials for Alzheimer’s disease
by: Shih-Ya Hung, et al.
Published: (2017-07-01) -
Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer’s Disease and Other Dementias
by: Taim Muayqil, et al.
Published: (2012-11-01) -
Evaluation of non-drug treatment options for Alzheimer's disease
by: Kim, Eun Sung
Published: (2018)